We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+37.77%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$201M
AUM Growth
-$75.4M
Cap. Flow
-$90M
Cap. Flow %
-44.86%
Top 10 Hldgs %
37.44%
Holding
107
New
50
Increased
2
Reduced
6
Closed
46

Sector Composition

Rank Sector Weight
1 Healthcare 22.36%
2 Technology 21.21%
3 Financials 19.53%
4 Industrials 9.42%
5 Communication Services 7.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHYM
101
PUT
Chime Financial
CHYM
$11.7B
-140,000
Closed -$4.83M
AIRO
102
PUT
AIRO Group Holdings
AIRO
$265M
-45,000
Closed -$1.08M
CAI
103
PUT
Caris Life Sciences
CAI
$6.61B
-65,000
Closed -$1.74M
SLDE
104
PUT
Slide Insurance Holdings
SLDE
$2.41B
-140,000
Closed -$3.03M
JCAP
105
Jefferson Capital
JCAP
$1.3B
-10,000
Closed -$185K

Similar funds

Monashee Investment Management's Q3 2025 Portfolio in Review

As of Q3 2025, Monashee Investment Management held 107 positions worth $201M, down 27% from $276M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Monashee Investment Management withdrew a net $90M in Q3 2025, closing 46 positions and reducing 6 holdings. Its most notable exit was Eli Lilly, an estimated $15.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Financials.

Against the trend, Monashee Investment Management opened a new position in Figure Technology Solutions worth $7.27M.

  • Monashee Investment Management's largest Q3 2025 buy was Figure Technology Solutions: 200,000 shares worth $7.27M.
  • Monashee Investment Management added most to Compass Therapeutics in Q3 2025, an estimated $3.43M increase.
  • Monashee Investment Management's biggest Q3 2025 reduction was Structure Therapeutics, cutting an estimated $4.58M.
  • Monashee Investment Management fully exited Eli Lilly in Q3 2025, selling an estimated $15.6M.
  • Monashee Investment Management's ten largest holdings make up 37% of its $201M portfolio in Q3 2025.
  • Monashee Investment Management opened 50 new positions and closed 46 in Q3 2025.
  • Monashee Investment Management's portfolio value fell 27% quarter-over-quarter to $201M.

Based on Monashee Investment Management's 13F filing for Q3 2025, filed 12 Nov 2025.